Evidence map›Paper›PMID 20206175›Full record

ArticleGastroenterology2010

Corticotropin-releasing hormone family of peptides regulates intestinal angiogenesis.

Eunok Im, Sang Hoon Rhee, Yong Seek Park, Claudio Fiocchi, Yvette Taché, Charalabos Pothoulakis

Open access · greenAbstract read
In one paragraph

Article in Gastroenterology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 1 synthesis or guideline pooled it, 70 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Human skin CD141iScience · 2023
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Role of G protein-coupled receptors-microRNA interactions in gastrointestinal pathophysiology.American journal of physiology. Gastrointestinal and liver physiology · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Eunok ImSection of Inflammatory Bowel Disease and Inflammatory Bowel Disease Center, Division of Digestive Diseases, David Geffen School of Medicine, UCLA, Los Angeles, California 90095, USA. eim@mednet.ucla.edu
Sang Hoon Rhee
Yong Seek Park
Claudio Fiocchi
Yvette Taché
Charalabos Pothoulakis
Cleveland Clinic · USKyung Hee University · KRUCLA Medical Center · US

Funding

Xenograft and Isograft CoreP01DK033506 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI REINECKER, HANS-CHRISTIAN · 1986 to 2015
$24.2M
Pilot and Feasibility ProgramP30DK041301 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ROZENGURT, JUAN ENRIQUE · 1990 to 2019
$18.0M
Cell interactions in the inflammed intestinal mucosaR01DK050984 · NIDDK · CLEVELAND CLINIC LERNER COM-CWRU · PI FIOCCHI, CLAUDIO · 1995 to 2014
$3.1M
The Role of Lymphangiogenesis in IBD PathogenesisR01DK069854 · NIDDK · CLEVELAND CLINIC LERNER COM-CWRU · PI DANESE, SILVIO, FIOCCHI, CLAUDIO · 2005 to 2014
$2.8M
CORTICOTROPIN-RELEASING FACTOR--BIOLOGICAL ACTIONR01DK033061 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI TACHE, YVETTE FRANCE · 1986 to 2012
$2.5M
Toll-like receptors and intestinal inflammationR01DK072417 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI POTHOULAKIS, CHARALABOS · 2006 to 2010
$1.5M
Innate Immune Response and Intestinal InflammationK01DK079015 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI RHEE, SANG HOON · 2008 to 2010
$450k
A Role for Neuropeptides in Intestinal AngiogenesisK01DK083336 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI IM, EUNOK · 2009 to 2011
$450k
NIDDK NIH HHS DK41301NIDDK NIH HHS K01 DK079015NIDDK NIH HHS K01 DK083336NIDDK NIH HHS KO1 DK079015NIDDK NIH HHS KO1 DK083336NIDDK NIH HHS P01 DK033506NIDDK NIH HHS P01 DK33506NIDDK NIH HHS P30 DK041301NIDDK NIH HHS R01 DK033061NIDDK NIH HHS R01 DK050984NIDDK NIH HHS R01 DK069854NIDDK NIH HHS R01 DK072417NIDDK NIH HHS R01 DK072471NIDDK NIH HHS R01 DK50894NIDDK NIH HHS R01 DK69854
6 · The paper itself

Abstract

BACKGROUND &

aimsThe corticotrophin-releasing hormone (CRH) family of peptides modulates intestinal inflammation and the CRH receptor 2 (CRHR2) suppresses postnatal angiogenesis in mice. We investigated the functions of CRHR1 and CRHR2 signaling during intestinal inflammation and angiogenesis.

methodsThe activities of CRHR1 and CRHR2 were disrupted by genetic deletion in mice or with selective antagonists. A combination of in vivo, ex vivo, and in vitro measures of angiogenesis were used to determine their activity. CRHR1(-/-) mice and CRHR2(-/-) mice with dextran sodium sulfate-induced colitis were analyzed in comparison with wild-type littermates (controls).

resultsColitis was significantly reduced in mice in which CRHR1 activity was disrupted by genetic deletion or with an antagonist, determined by analyses of survival rate, weight loss, histological scores, and cytokine production. Inflammation was exacerbated in mice in which CRHR2 activity was inhibited by genetic deletion or with an antagonist, compared with controls. The inflamed intestines of CRHR1(-/-) mice had reduced microvascular density and expression of vascular endothelial growth factor (VEGF)-A, whereas the intestines of CRHR2(-/-) mice had increased angiogenesis and VEGF-A levels. An antagonist of VEGFR2 activity alleviated colitis in CRHR2(-/-) mice. Ex vivo aortic vessel outgrowth was reduced when CRHR1 was deficient but increased when CRHR2 was deficient. The CRHR1 preferred agonist CRH stimulated tube formation, proliferation, and migration of cultured intestinal microvascular endothelial cells by phosphorylating Akt, whereas the specific CRHR2 agonist Urocortin III had opposite effects.

conclusionCRHR1 promotes intestinal inflammation, as well as endogenous and inflammatory angiogenesis whereas CRHR2 inhibits these activities.

Indexed as

Angiogenesis InhibitorsAnimalsCells, CulturedColitisCRF Receptor, Type 1Dextran SulfateFemaleIntestinesMaleMiceNeovascularization, PathologicPhosphorylationProto-Oncogene Proteins c-aktReceptors, Corticotropin-Releasing HormoneVascular Endothelial Growth Factor Receptor-2Angiogenesis InhibitorsCRF Receptor, Type 1CRF receptor type 2Dextran SulfateProto-Oncogene Proteins c-aktReceptors, Corticotropin-Releasing HormoneVascular Endothelial Growth Factor Receptor-2

Identifiers

PMID20206175
PMCPMC2883634
OpenAlexW2044413542

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.